Intracellular controlled release prolongs the time period of siRNA-based gene suppression

References

• Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806–811.
   PubMed Web of Science ®Google Scholar
• Hammond SM, Bernstein E, Beach D, et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in drosophila cells. Nature. 2000;404(6775):293–296.
   PubMed Web of Science ®Google Scholar
• Tomari Y, Zamore PD. Perspective: machines for RNAi. Genes Dev. 2005;19(5):517–529.
   PubMed Web of Science ®Google Scholar
• Sibley CR, Seow Y, Wood MJ. Novel RNA-based strategies for therapeutic gene silencing. Mol Ther. 2010;18(3):466–476.
   PubMed Web of Science ®Google Scholar
• Grimm D, Streetz KL, Jopling CL, et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature. 2006;441(7092):537–541.
   PubMed Web of Science ®Google Scholar
• Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference-based therapeutics. Nature. 2009;457(7228):426–433.
   PubMed Web of Science ®Google Scholar
• Humphreys IR, Sebastian S. Novel viral vectors in infectious diseases. Immunology. 2018;153(1):1–9.
   PubMed Web of Science ®Google Scholar
• Gao K, Huang L. Nonviral methods for siRNA delivery. Mol Pharm. 2009;6(3):651–658.
   PubMedGoogle Scholar
• Yin H, Kanasty RL, Eltoukhy AA, et al. Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014;15(8):541–555.
   PubMed Web of Science ®Google Scholar
• Kim B, Park JH, Sailor MJ. Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery. Adv Mater. 2019;31(49):e1903637.
   PubMed Web of Science ®Google Scholar
• Sato Y, Murase K, Kato J, et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol. 2008;26(4):431–442.
   PubMed Web of Science ®Google Scholar
• Buyens K, De Smedt SC, Braeckmans K, et al. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. J Control Release. 2012;158(3):362–370.
   PubMed Web of Science ®Google Scholar
• Hattori Y, Shimizu S, Ozaki KI, et al. Effect of cationic lipid type in Folate-PEG-Modified cationic liposomes on folate Receptor-Mediated siRNA transfection in tumor cells. Pharmaceutics. 2019;11(4):181.
   Web of Science ®Google Scholar
• Matsumoto S, Christie RJ, Nishiyama N, et al. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules. 2009;10(1):119–127.
   PubMed Web of Science ®Google Scholar
• Brown A, Patel S, Ward C, et al. PEG-lipid micelles enable cholesterol efflux in Niemann-Pick type C1 disease-based lysosomal storage disorder. Sci Rep. 2016;6:31750.
   PubMed Web of Science ®Google Scholar
• Dunn SS, Tian S, Blake S, et al. Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing. J Am Chem Soc. 2012;134(17):7423–7430.
   PubMed Web of Science ®Google Scholar
• Cavallaro G, Sardo C, Craparo EF, et al. Polymeric nanoparticles for siRNA delivery: production and applications. Int J Pharm. 2017;525(2):313–333.
   PubMedGoogle Scholar
• Delong RK, Reynolds CM, Malcolm Y, et al. Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules. Nanotechnol Sci Appl. 2010;3:53–63.
   PubMedGoogle Scholar
• Paul AM, Shi Y, Acharya D, et al. Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro. J Gen Virol. 2014;95(Pt 8):1712–1722.
   PubMedGoogle Scholar
• Matsui M, Tabata Y. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater. 2012;8(5):1792–1801.
   PubMed Web of Science ®Google Scholar
• Saito T, Tabata Y. Hypoxia-induced angiogenesis is increased by the controlled release of deferoxiamine from gelatin hydrogels. Acta Biomater. 2014;10(8):3641–3649.
   PubMed Web of Science ®Google Scholar
• Kim YH, Tabata Y. Recruitment of mesenchymal stem cells and macrophages by dual release of stromal cell-derived factor-1 and a macrophage recruitment agent enhances wound closure. J Biomed Mater Res A. 2016;104(4):942–956.
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Tomoshige R, Iwanaga K, et al. Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds. J Control Release. 2006;112(2):249–256.
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Tomoshige R, Iwanaga K, et al. In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds. J Biomater Sci Polym Ed. 2006;17(6):645–658.
   PubMed Web of Science ®Google Scholar
• Doi N, Jo J-I, Tabata Y. Preparation of biodegradable gelatin nanospheres with a narrow size distribution for carrier of cellular internalization of plasmid DNA. J Biomater Sci Polym Ed. 2012;23(8):991–1004.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Nakamura Y, Jo J-I, et al. Gelatin nanospheres incorporating siRNA for controlled intracellular release. Biomaterials. 2012;33(35):9097–9104.
   PubMed Web of Science ®Google Scholar
• Murata Y, Jo JI, Tabata Y. Intracellular controlled release of molecular beacon prolongs the time period of mRNA visualization. Tissue Eng Part A. 2019;25(21-22):1527–1537.
   PubMed Web of Science ®Google Scholar
• Fukunaka Y, Iwanaga K, Morimoto K, et al. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release. 2002;80(1-3):333–343.
   PubMed Web of Science ®Google Scholar
• Snyder SL, Sobocinski PZ. An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem. 1975;64(1):284–288.
   PubMed Web of Science ®Google Scholar
• Murata Y, Jo JI, Tabata Y. Preparation of cationized gelatin nanospheres incorporating molecular beacon to visualize cell apoptosis. Sci Rep. 2018;8(1):14839.
   PubMedGoogle Scholar
• Dim N, Perepelyuk M, Gomes O, et al. Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluation. J Nanobiotechnology. 2015;13:61.
   PubMed Web of Science ®Google Scholar
• Wang Y, Malcolm DW, Benoit DSW. Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing. Biomaterials. 2017;139:127–138.
   PubMed Web of Science ®Google Scholar
• Aldayel AM, O'Mary HL, Valdes SA, et al. Lipid nanoparticles with minimum burst release of TNF-alpha siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate. J Control Release. 2018;283:280–289.
   PubMed Web of Science ®Google Scholar
• Rejman J, Oberle V, Zuhorn IS, et al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 2004;377(1):159–169.
   PubMedGoogle Scholar
• Ur Rehman Z, Hoekstra D, Zuhorn IS. Mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: real-time visualization of transient membrane destabilization without endosomal lysis. ACS Nano. 2013;7(5):3767–3777.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657–3666.
   PubMed Web of Science ®Google Scholar
• Frohlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012;7:5577–5591.
   PubMed Web of Science ®Google Scholar